The determination of capreomycin in human plasma by LC-MS/MS using ion-pairing chromatography and solid-phase extraction.
The determination of capreomycin in human plasma by LC-MS/MS using ion-pairing chromatography and solid-phase extraction.
复制标题
使用离子对色谱和固相萃取，通过 LC-MS/MS 测定人血浆中的卷曲霉素。
DOI：
10.1002/bmc.4269
复制
发表时间：
2018
期刊：
影响因子：
--
通讯作者：
Wiesner,Lubbe
中科院分区：
文献类型：
--
作者：
Thuboy,Blessings;Kellermann,Tracy;Castel,Sandra;Norman,Jennifer;Joubert,Anton;Garcia-Prats,AnthonyJ;Hesseling,AnnekeC;Wiesner,Lubbe
A bioanalytical method was developed and validated for the quantification of capreomycin (Cm) analogs, Cm IA and Cm IB, in human plasma. This implemented ion‐pairing solid phase extraction, followed by ion‐pairing high‐performance liquid chromatography, with tandem mass spectrometry detection. Chromatographic separation was achieved using a Discovery C18, 5 μm, 4.6 × 50 mm analytical column. An isocratic mobile phase consisting of water and acetonitrile with 0.1% formic acid and 4mmheptafluorobutyric acid (80:20; v/v) was used at a flow‐rate of 500 μL/min. An AB Sciex API 3000 mass spectrometer at unit resolution, in multiple reaction monitoring mode, was used for detection. Electrospray ionization was used for ion production. The method was successfully validated for the range 469–30,000 ng/mL for Cm IA and for Cm IB, with cefotaxime as the internal standard. The within‐ and between‐day precision determinations for Cm IA and IB, expressed as the percentage coefficient of variation, were < 20.0% at the lower limit of quantification (LLOQ) and < 8.2% at all other test concentrations. Recovery of both analogs was > 72.3% and reproducible at the low, medium and high end of the calibration range. No significant matrix effects were observed for the analyte. The assay performed well when applied to clinical samples generated from children in a clinical multidrug resistant tuberculosis research study in South Africa.
登录
查看更多内容
基于生理学的卷曲霉素药代动力学模型
影响因子：
4.9
作者：
B. Reisfeld;C. Metzler;M. A. Lyons;A. N. Mayeno;Elizabeth J. Brooks;M. A. Degroote
通讯作者：
M. A. Degroote
影响因子：
3.7
作者：
Fiegel, Jennifer;Garcia-Contreras, Lucila;Edwards, David
通讯作者：
Edwards, David
影响因子：
7.4
作者：
Matuszewski, BK;Constanzer, ML;Chavez-Eng, CM
通讯作者：
Chavez-Eng, CM
卷曲霉素在正常和患病状态下的吸收、排泄和代谢
影响因子：
5.2
作者：
H. Black;R. Griffith;A. Peabody
通讯作者：
A. Peabody
通过液相色谱/大气压化学电离质谱同时测定候选药物混合物作为体内药物筛选程序。
影响因子：
2
作者：
T. Olah;D. McLoughlin;J. Gilbert
通讯作者：
J. Gilbert